Brian DeSchuytner

Insider Reports History

Location
Cambridge, MA
Signature
/s/ Brian DeSchuytner
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Brian DeSchuytner:

Company Role Class Num Shares Value Price $ Report Date Ownership
Mersana Therapeutics, Inc. SVP, COO & CFO Restricted Stock Units 0 $158,082 $2.71 06 Jan 2026 Direct
Mersana Therapeutics, Inc. SVP, COO & CFO Restricted Stock Unit 62,500 $36,250 $0.5800 15 Jan 2025 Direct
Mersana Therapeutics, Inc. SVP, COO & CFO Common Stock 0 $0 $28.14 06 Jan 2026 Direct
Mersana Therapeutics, Inc. SVP, COO & CFO Stock Option (right to buy) 0 06 Jan 2026 Direct

Insider Reports Filed by Brian DeSchuytner

Symbol Company Period Transactions Value $ Form Type Role Filing Time
MRSN Mersana Therapeutics, Inc. 06 Jan 2026 19 $0 4 SVP, COO & CFO 06 Jan 2026, 16:38
MRSN Mersana Therapeutics, Inc. 15 Jan 2025 7 -$4,913 4 SVP, COO & CFO 17 Jan 2025, 19:20
MRSN Mersana Therapeutics, Inc. 14 Jan 2025 3 -$1,469 4 SVP, COO & CFO 16 Jan 2025, 17:23
MRSN Mersana Therapeutics, Inc. 13 Jan 2025 3 -$2,451 4 SVP, COO & CFO 15 Jan 2025, 21:17
MRSN Mersana Therapeutics, Inc. 01 Oct 2024 4 -$27,150 4 SVP, COO & CFO 07 Oct 2024, 17:48
MRSN Mersana Therapeutics, Inc. 13 Jan 2024 11 -$25,276 4 SVP, COO & CFO 17 Jan 2024, 17:18
MRSN Mersana Therapeutics, Inc. 05 Sep 2023 1 $0 4 SVP, COO and CFO 07 Sep 2023, 18:51
MRSN Mersana Therapeutics, Inc. 13 Jan 2023 9 -$29,452 4 SVP, Chief Financial Officer 18 Jan 2023, 19:12
MRSN Mersana Therapeutics, Inc. 14 Jan 2022 5 $0 4 Chief Financial Officer 19 Jan 2022, 16:45